2014/11

Genecast Biotechnology was established in the PRC.

2016/01

We launched Genecast Comprehensive.

2017/06

We launched Genecast PD-L1.

2017/07

We launched Genecast Lung and Genecast CRC.

2017/12

We were awarded National High-tech Enterprise Certificate.

2018/04

Wuxi Genecast Laboratory obtained the Practice License of Medical Institution.

2018/09

We launched MammaPrint^® licensed from Agendia in China.

2018/10

Wuxi laboratory was certified by U.S. College of American Pathologist.

2018/12

Taizhou manufacturing facility obtained the YY/T0287- 2017 idt ISO 13485:2016 certification.

2019/09

Wuxi laboratory was certified as a PCR laboratory to carry out “tumor-related genetic testing activities (with conventional ARMS method and NGS method)”.

2019/09

Awarded 2019 EY Fudan China Most Promising Enterprises Award by Ernst & Young.

2019/11

We launched Genecast Lung TILs.

2020/04

We launched Genecast RNA Fusion Focus.

2020/11

We launched Genecast MRD – Lung.

2020/11

We launched TumorX with the participation of Zhejiang University.

2021/02

We obtained our first IVD product registration certificate from NMPA for Genecast IVD – KNBP.

2021/07

We launched Genecast Genius G1 and Genecast INTEGRO V1.0, both certified by NMPA.

2021/08

We launched Immunoscore^® licensed from Veracyte in China.

2021/11

We launched Tissue of Origin^® in China.

2022/02

We launched Genecast MRD – CRC.

2022/03

We obtained CE marking for 5 Genecast IVD products.

2022/06

We launched Genecast MRD – Comprehensive.

2022/07

Our new Taizhou manufacturing facility commenced operations.

2022/08

We received a Class II medical device registration certificate from Jiangsu MPA for our Genecast Genius X.